I'm not sure there's a causal relationship between ZLCS' surge (11% at close) and the Remoxy news, but it's interesting nonetheless.
Try checking out other boards from time to time or other stocks. Many small cap pharmas shot up in the closing minutes . . . Courtesy of buyBio and Invest2win on FDA Plays:(ALXA, BPAX, PATH, TSPT, AIS, BIOD, OSIR, NBY, LXRX). ZLCS's rise most likely has nothing to do with Remoxy's rejection. I do not have an explanation for why so many stocks shot up at the end.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.